Women with irregular heart rhythm carry a higher risk of stroke than men

May 31, 2012

Women with irregular heart rhythm (known as atrial fibrillation) have a moderately increased risk of stroke compared with men, suggesting that female sex should be considered when making decisions about anti-clotting treatment, finds a study published on BMJ today.

Several studies have suggested that with are at higher risk for ischaemic stroke (caused by an of the blood supply to the brain) than men, but other studies found no such difference.

If few or no other exist, need to know whether female sex is important in making decisions about anti-clotting treatment.

So researchers based at the Karolinska Institute in Sweden and the University of Birmingham in the UK decided to investigate whether women with atrial fibrillation have higher risk of stroke than men.

The study involved over 100,000 patients with a of atrial fibrillation at any Swedish hospital or hospital affiliated outpatient clinic. Participants were tracked for an average of 1.2 years (a total of 139,504 years at risk - a term that adds up the time each person in the study was at risk).

In this period there were 7,221 patients who had thromboembolic strokes due to clots, while ischaemic strokes (due to lack of blood supply to the brain) were more common: there were 4,264 strokes during 69,005 years at risk in women, and 2,957 strokes during 70,594 years at risk in men, corresponding to overall annual stroke rates of 6.2% and 4.2% respectively.

Even after adjusting for 35 factors that could have influenced the results, women still had an 18% higher risk of stroke than men. The absolute risks were low for both sexes, however: the annual rate of stroke was 1.9% for women aged 65-74 and was lower for men.

Furthermore, women younger than 65 years and without any other risk factors (apart from atrial fibrillation) did not have a higher risk of stroke than men. There were 31 strokes in women (during 4,626 years at risk) and 53 strokes in men (during 11,677) and this difference was not statistically significant.

The authors conclude that women with atrial fibrillation have a moderately increased risk of stroke compared with men, and thus, female sex should be considered when about anti-clotting treatment. They add: "In borderline situations, in which a decision about whether to give anticoagulation treatment weighs in the balance, we suggest that female sex should probably tip the scale towards initiating treatment."

However, they say that women younger than 65 years and without other risk factors have a low risk for stroke, and do not need anticoagulation treatment.

In an accompanying editorial, Professor Eva Prescott from the University Hospital, Bispebjerg in Denmark says, despite some inherent weaknesses, this and other registry studies provide reassurance to clinicians. "The registry data confirm overall that women are at higher risk of stroke than men, but when differences in age and risk factor profile are taken into account the excess risk is low," she writes. "More importantly, the absolute risk in younger women with no other is low and does not merit treatment with oral anticoagulants."

Explore further: Rheumatoid arthritis linked to irregular heart rhythm

Related Stories

Rheumatoid arthritis linked to irregular heart rhythm

March 8, 2012
People with rheumatoid arthritis are at a greater risk of irregular heart rhythm (known as atrial fibrillation) and stroke compared with the general population, finds a study published in the British Medical Journal today.

Risk of stroke greater for women than men among older patients diagnosed with atrial fibrillation

May 8, 2012
In a study that examined use of the anticoagulant medication warfarin and risk of stroke following a diagnosis of atrial fibrillation in older patients, women, especially those 75 years or older, had a higher risk of stroke ...

UK doctors still undertreating atrial fibrillation - major risk factor for stroke

October 13, 2011
Despite significant improvements in stroke prevention over the past decade, and a fall in incidence and deaths, UK doctors are still undertreating one of the major risk factors - atrial fibrillation - reveals research published ...

Atrial fibrillation associated with increased risk of death and cardiovascular events in women

May 24, 2011
Researchers at Brigham and Women's Hospital (BWH) have found that among women who are mostly healthy, those diagnosed with atrial fibrillation have an increased risk of death when compared to women without atrial fibrillation. ...

Atrial arrhythmias detected by pacemakers increase risk of stroke

January 11, 2012
An irregular heartbeat that you don't even feel but can be picked up by a pacemaker is associated with a significantly increased risk of stroke, says a new McMaster University study.

Recommended for you

Could aggressive blood pressure treatments lead to kidney damage?

July 18, 2017
Aggressive combination treatments for high blood pressure that are intended to protect the kidneys may actually be damaging the organs, new research from the University of Virginia School of Medicine suggests.

Quantifying effectiveness of treatment for irregular heartbeat

July 17, 2017
In a small proof-of-concept study, researchers at Johns Hopkins report a complex mathematical method to measure electrical communications within the heart can successfully predict the effectiveness of catheter ablation, the ...

Concerns over side effects of statins stopping stroke survivors taking medication

July 17, 2017
Negative media coverage of the side effects associated with taking statins, and patients' own experiences of taking the drugs, are among the reasons cited by stroke survivors and their carers for stopping taking potentially ...

Study discovers anticoagulant drugs are being prescribed against safety advice

July 17, 2017
A study by researchers at the University of Birmingham has shown that GPs are prescribing anticoagulants to patients with an irregular heartbeat against official safety advice.

Protein may protect against heart attack

July 14, 2017
DDK3 could be used as a new therapy to stop the build-up of fatty material inside the arteries

Heart study finds faulty link between biomarkers and clinical outcomes

July 14, 2017
Surrogate endpoints (biomarkers), which are routinely used in clinical research to test new drugs, should not be trusted as the ultimate measure to approve new health interventions in cardiovascular medicine, according to ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.